Baseline characteristics (n=27)
| Age (years) | 46 (39, 55) |
| Follow-up (days) | 245 (70, 842) |
| Female sex | 14 (52%) |
| Chest pain | 24 (89%) |
| Typical angina | 12 (44%) |
| Atypical angina | 7 (26%) |
| Non-anginal pain | 5 (19%) |
| Exertional dyspnoea | 16 (59%) |
| NYHA class | I: 11 (41%), II 11 (41%), III 5 (19%) |
| Presyncope/syncope | 8 (30%) |
| Known CAD | 1 (4%) |
| Diabetes mellitus | 3 (11%) |
| Hypertension | 14 (52%) |
| Hyperlipidaemia | 14 (52%) |
| Current smoking | 4 (15%) |
| Aspirin | 13 (48%) |
| Statin | 9 (33%) |
| β-blockers | 15 (56%) |
| ACEi/ARB | 5 (19%) |
| CCB | 5 (19%) |
| Diuretic | 6 (22%) |
Expressed as median (IQR) or n (%).
ACEi, ACE inhibitor; ARB, angiotensin receptor blocker; CAD, coronary artery disease; CCB, calcium channel blocker; NYHA, New York Heart Association.